This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari +5 more
wiley +1 more source
Current economic and regulatory challenges in developing antibiotics for Gram-negative bacteria. [PDF]
Gargate N, Laws M, Rahman KM.
europepmc +1 more source
Prevalence and antimicrobial drug resistance of gram-negative bacteria in dairy feed and water: a One Health concern. [PDF]
Arbab S +8 more
europepmc +1 more source
Pharmacodynamic studies of taniborbactam (VNRX-5133) combined with cefepime against β-lactamase-producing Gram-negative bacteria in a neutropenic murine thigh infection model. [PDF]
Georgiou PC +6 more
europepmc +1 more source
Spectrum, dose, and duration of antibiotic exposure and risk of intensive care unit-acquired carbapenem-resistant gram-negative bacteria: a prospective cohort study. [PDF]
Chen Z +9 more
europepmc +1 more source
Clinical characteristics and influencing factors of severe influenza A virus pneumonia in children coinfected with gram-negative bacteria: A retrospective analysis. [PDF]
Wang QY +7 more
europepmc +1 more source
In Vitro Evaluation of the Antimicrobial Activity of Eighteen Essential Oils Against Gram-Positive and Gram-Negative Bacteria in Two Different Growth Media. [PDF]
Marianelli C +3 more
europepmc +1 more source

